Phillip G. Febbo, Chief Medical Officer at GENOMIC HEALTH INC (GHDX), sold 4,405 shares at $30.63 ($135K) on 2017-02-16, disclosed to the SEC on 2017-02-17.
Scheduled sale ($135k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.12 | 1,910 | $59K | 44.2% |
| 2 | $29.56 | 1,269 | $38K | 27.9% |
| 3 | $30.63 | 1,226 | $38K | 27.9% |
| Total | $30.53 avg | 4,405 | $135K | 100% |
| Filing → |
| VCYT | SELL | 2025-10-07 | $601K | — | Filing → |
| VCYT | SELL | 2025-03-06 | $536K | — | Filing → |
| VCYT | SELL | 2024-12-06 | $347K | — | Filing → |